Amylo-Pipe: New Web Tool Predicts Protein Aggregation Kinetics for Drug Development
Researchers have developed Amylo-Pipe, a freely accessible web server that unifies multiple state-of-the-art tools for predicting protein and peptide aggregation behavior, including both mechanistic and kinetic modeling. Protein aggregation underlies amyloid-related diseases such as Alzheimer's and Parkinson's, and poses significant challenges in the development of protein-based therapeutics. The tool addresses a longstanding gap in the field, where aggregation propensity scores were commonly—but often inaccurately—used as proxies for aggregation kinetics.
Amylo-Pipe is a newly introduced web server designed to provide a comprehensive, integrated platform for predicting protein and peptide aggregation, combining mechanistic and kinetic prediction tools in a single user-friendly interface. The tool was developed in response to a recognized limitation in the field: while algorithms for identifying aggregation-prone regions (APRs) have been widely used to infer aggregation kinetics, large-scale studies have shown that aggregation propensity and kinetics correlate only weakly or inconsistently. By consolidating complementary prediction approaches, Amylo-Pipe aims to offer more reliable assessments of aggregation behavior than APR-only workflows. The server also includes practical features for protein engineering, notably gatekeeper-residue mutational scanning, which can assist researchers in designing aggregation-resistant protein variants. This capability is particularly relevant for the biopharmaceutical industry, where aggregation is a major obstacle in the development and stability of therapeutic proteins. The web server is freely available at https://web.iitm.ac.in/bioinfo2/amylopipe/, lowering the barrier for researchers without specialized computational expertise to access advanced aggregation prediction methods.
What's missing
The preprint does not report experimental validation benchmarks comparing Amylo-Pipe's integrated predictions against existing standalone tools on independent datasets, making it difficult to quantify the performance improvement over current approaches.
What different sources said
- bioRxivCenter
Amylo-Pipe: an integrated web server for mechanistic and kinetic prediction of protein and peptide aggregation
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.